Needle-free, wireless continuous glucose monitoring device company Echo Therapeutics has parted company with its CEO, Dr Patrick Mooney, for reasons not thus far disclosed. Board member Robert Doman is stepping into the breach for the time being.
Tom Dugan Joins SurgiQuest, Inc. as President and Chief Commercialization Officer (via PR Newswire) MILFORD Conn., June 20, 2013 /PRNewswire/ … continue reading “S&N Man Dugan Is SurgiQuest’s New President”
Ex-staffer Brad Mason returns to Orthofix as President and Chief Exec, filling the shoes of the outgoing Robert Vaters.
Steven Ek has been named ArthroSurface’s President and Chief Executive Officer, effective November 20, 2012. Mr. Ek is one of the original founders in Arthrosurface and a Director since inception.
Orthopaedic device company Tornier, N.V. has announced that its Board of Directors has appointed David H. Mowry as President and Chief Executive Officer, effective immediately.
Cyberonics, Inc. says Bruce H. KenKnight , Ph.D., has joined the company as its Vice President, Emerging Therapies. Dr. KenKnight will lead all of the company’s emerging therapies programs, including the current clinical evaluation of Autonomic Regulation Therapy.
Johnson & Johnson’s DePuy Synthes Spine business has a new Worldwide president in the form of Max Reinhardt, a long term employee of the company and most recently Vice President of Worldwide Marketing.
Smith & Nephew plc has announced the appointment of Julie Brown as Chief Financial Officer. She will formally take up the post by early February 2013, when she will also be appointed to the Board as an Executive Director.
Just a month after taking the hot seat, Kevin Lobo has had something we Brits might call a cabinet reshuffle, bringing in a new man to replace himself in heading up the company’s vital orthopedics business.
Michael Carrel has been appointed as President and Chief Executive Officer of AtriCure, Inc., a leading manufacturer of cardiac surgical ablation systems for the treatment of atrial fibrillation(AF), and systems for the exclusion of the left atrial appendage.
sBioMed, which describes itself as an emerging leader in infection control, has announced that Stephen P. MacMillan, former Chairman and CEO of Stryker, has joined as Chief Executive Officer and become an owner of the company.
It seems like he’s been there for ages… because he has. Now after a year sorting out his previous responsibilities to former employer J&J among other things, Mike Mahoney formally takes the CEO and President reigns at Boston Scientific.
Clever non-invasive glucose monitor measures levels using light. The device is now CE marked for use as an adjunct to conventional invasive techniques.
It’s an incredibly clever device the ReWalk Exoskeleton, relying as it does in changes in posture and attitude to drive its limbs. You might have seen it being worn by Claire Lomas at the Paralympics. Now you can buy one for personal use.
Stryker Corporation’s Board of Directors announced today that Kevin A. Lobo has been named the Company’s President and Chief Executive Officer, effective immediately. He has also been named to the Company’s Board of Directors. Mr. Lobo joined Stryker in April 2011, and was most recently Group President of Stryker Orthopaedics.
InspireMD, Inc. has announced that Ofir Paz, co-founder, board member and Chief Executive Officer of InspireMD since its founding in 2005, intends to step down as CEO as part of a planned transition to prepare the Company for formal commercialisation of its proprietary MGuard™ Embolic Protection Stent (EPS) platform technology for patients with Acute Myocardial Infarction.